Pharmacological targeting of casein kinase 1δ suppresses oncogenic NRAS-driven melanoma.
Wen Y, Wang H, Yang X, Zhu Y, Li M, Ma X, Huang L, Wan R, Zhang C, Li S, Jia H, Guo Q, Lu X, Li Z, Shen X, Zhang Q, Si L, Yin C, Liu T.
Wen Y, et al. Among authors: yin c.
Nat Commun. 2024 Nov 21;15(1):10088. doi: 10.1038/s41467-024-54140-1.
Nat Commun. 2024.
PMID: 39572526
Free PMC article.